Product NDC: | 66758-046 |
Proprietary Name: | Fludarabine Phosphate |
Non Proprietary Name: | Fludarabine Phosphate |
Active Ingredient(s): | 25 mg/mL & nbsp; Fludarabine Phosphate |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 66758-046 |
Labeler Name: | Sandoz Inc |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA022137 |
Marketing Category: | NDA |
Start Marketing Date: | 20071012 |
Package NDC: | 66758-046-01 |
Package Description: | 1 VIAL, SINGLE-DOSE in 1 CARTON (66758-046-01) > 2 mL in 1 VIAL, SINGLE-DOSE |
NDC Code | 66758-046-01 |
Proprietary Name | Fludarabine Phosphate |
Package Description | 1 VIAL, SINGLE-DOSE in 1 CARTON (66758-046-01) > 2 mL in 1 VIAL, SINGLE-DOSE |
Product NDC | 66758-046 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Fludarabine Phosphate |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 20071012 |
Marketing Category Name | NDA |
Labeler Name | Sandoz Inc |
Substance Name | FLUDARABINE PHOSPHATE |
Strength Number | 25 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC] |